THE ROLE OF REDUCTASES IN DRUG DISCOVERY AND DEVELOPMENT

被引：0

|

作者：

Di, Li ^{[1
]}

机构：

[1] Pfizer Inc, New York, NY USA

来源：

DRUG METABOLISM AND PHARMACOKINETICS | 2019年 / 34卷 / 01期

关键词：

D O I：

10.1016/j.dmpk.2018.09.216

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P136

引用

收藏

页码：S62 / S62

页数：1

相关论文

共 50 条

[31] The role of Natural Products in Drug Discovery and development in the New Millennium
Harvey, Alan
IDRUGS, 2010, 13 (02) : 70 - 72
[32] Expanding Role of Data Science and Bioinformatics in Drug Discovery and Development
Fingert, Howard J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 47 - 49
[33] The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Wong, Dean F.
Tauscher, Johannes
Gruender, Gerhard
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (01) : 187 - 203
[34] The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Dean F Wong
Johannes Tauscher
Gerhard Gründer
Neuropsychopharmacology, 2009, 34 : 187 - 203
[35] Biomarker discovery by proteomics and its role in drug and diagnostic development
Carr, S
FASEB JOURNAL, 2004, 18 (08): : C306 - C306
[36] The role of functional and molecular imaging in cancer drug discovery and development
Seddon, BM
Workman, P
BRITISH JOURNAL OF RADIOLOGY, 2003, 76 : S128 - S138
[37] Drug Discovery and Development
Duboc, Carole
Flitsch, Sabine L.
JACS AU, 2024, 4 (02): : 276 - 278
[38] Drug discovery & development
Nature Biotechnology, 2004, 22 (7) : 907 - 907
[39] Drug discovery & development
Nature Biotechnology, 2003, 21 (8) : 949 - 949
[40] Drug discovery and development
Nature Biotechnology, 2001, 19 (8) : 785 - 785

← 1 2 3 4 5 →